ReviewJournal of perinatology : official journal of the California Perinatal Association2026
Microplastics exposure during perinatal period: Impacts on neonatal immune and metabolic programming - a scoping review.
Review in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This scoping review synthesizes research on "Microplastics Exposure During Perinatal Period: Impacts on Neonatal Immune and Metabolic Programming " to address gaps in understanding how micro- and nano plastics affect neonatal physiological systems and health trajectories. This scoping review aims to evaluate mechanisms of immune and metabolic disruption, benchmark experimental models, characterize size- and dose-dependent effects, and elucidate exposure pathways influencing neonatal outcomes. This also analyses the experimental animal studies, human clinical data, and in vitro models, focusing on biodistribution, molecular effects, and long-term consequences. Findings reveal that micro- and nano plastics cross placental and lactational barriers, accumulating in fetal and neonatal tissues, with smaller particles exhibiting greater translocation and toxicity. Immune programming is disrupted via inflammation, oxidative stress, and gut microbiota dysbiosis, while metabolic disturbances include lipid dysregulation, hepatic inflammation, and persistent obesity risk. Neurodevelopmental impairments and reproductive toxicity with transgenerational effects were documented predominantly in animal models. Methodological heterogeneity and limited human longitudinal data constrain translational relevance. Integrating these findings underscores the critical impact of early-life microplastic exposure on immune and metabolic programming with potential lifelong health consequences. These insights highlight the need for standardized exposure assessment, multidisciplinary research, and targeted public health interventions to mitigate risks during sensitive developmental windows.
Identifiers
41667624What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.